Skip to main content

Superselective Therapy for Cerebral Gliomas

  • Chapter
Interventional Neuroradiology

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

Abstract

The natural history of glioblastomas has been little altered by therapeutic attempts over the past 30 years. Surgical debulking and radiation therapy have had only a moderate effect on these patients (Neuwelt and Dahlborg 1989), with the median survival being in the range of 7.5–9.5 months (Edwards et al. 1980; Shapiro and Ausman 1969). This dismal prognosis for patients with glioblastomas has stimulated the development of many alternative regimens, such as intra-arterial therapy and local high dose irradiation. This chapter will initially discuss the rationale behind the chemotherapy of brain tumors, the nature of the bloodbrain barrier (BBB) and its significance in the treatment of patients with cerebral glioblastomas, and the problem with the BBB; it will conclude with a discussion on the intra-arterial delivery of chemotherapeutic agents.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Baba T, Fukui M, Takeshita I et al. (1990) Selective enhancement of intratumoral blood flow in malignant gliomas using intra-arterial adenosine triphosphate. J Neurosurg 72:907–911

    Article  PubMed  CAS  Google Scholar 

  • Barranco SC, Humphrey RM (1971) The effects of BCNU on survival and cell progression in Chinese hamster cells. Cancer Res 31:191–195

    PubMed  CAS  Google Scholar 

  • Bashir R, Hochberg FH, Linggood RM, Hottleman K (1988) Preirradiation internal carotid artery BCNU in treatment of glioblastoma multiforme. J Neurosurg 68:917–919

    Article  PubMed  CAS  Google Scholar 

  • Black KL, King WA, Ikezaki K (1990) Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4. J Neurosurg 72:912–916

    Article  PubMed  CAS  Google Scholar 

  • Charnsangavej C, Lee Y, Carrasco CH et al. (1985) Supraclinoid intracarotid chemotherapy using a flow-directed soft-tipped catheter. Radiology 155:655–657

    PubMed  CAS  Google Scholar 

  • Clayman DA, Wolpert SM, Heros DO (1989) Super-selective arterial BCNU infusion in the treatment of patients with malignant gliomas. AJNR 10:767–771

    PubMed  CAS  Google Scholar 

  • DiChiro G, Oldfield E, Wright DC et al. (1987) Cerebral necrosis after radiotherapy and/or intra-arterial chemotherapy for brain tumors: PET and neuropathologic studies. AJNR 8:1083–1091

    Google Scholar 

  • Doppman JL, Dedrick RL, Shook DR et al. (1986) Glioblastoma: catheter techniques for isolated chemotherapy perfusion. Radiology 159:477–483

    PubMed  CAS  Google Scholar 

  • Edwards MS, Levin VA, Wilson CB (1980) Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials. Cancer Treat Rep 64:1179–1205

    PubMed  CAS  Google Scholar 

  • Fauchon F, Davila L, Chatellier G et al. (1990) Treatment of malignant gliomas with surgery, intra-arterial infusions of l-(2-hydroxyethyl) chloroethylnitrosourea, and radiation therapy: a phase II study. Neurosurgery 27:231–234

    Article  PubMed  CAS  Google Scholar 

  • Fenstermacher JD, Cowles AL (1977) Theoretic limitations of intracarotid infusions in brain tumor chemotherapy. Cancer Treat Rep 61:519–526

    PubMed  CAS  Google Scholar 

  • Foo SH, Ransohoff J, Choi IS et al. (1985) Experience with supraophthalmic intra-arterial BCNU infusion in malignant glioma (abstr). Neurology 35 [Suppl]:114

    Google Scholar 

  • Greenberg HS, Ensminger WD, Seeger JF et al. (1981) Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: a preliminary report. Cancer Treat Rep 65:803–810

    PubMed  CAS  Google Scholar 

  • Greig NH (1989a) Drug delivery to the brain by blood-brain barrier circumvention and drug modification. In: Neuwelt EA (ed) Implications of the blood-brain barrier barrier barrier and its manipulations. Plenum Medical, New York, pp 311–367

    Chapter  Google Scholar 

  • Greig NH (1989b) Brain tumors and the blood-tumor barrier. In: Neuwelt EA (ed) Implications of the blood-brain barrier and its manipulation. Plenum Medical, New York, pp 77–106

    Google Scholar 

  • Groothuis DR, Warkne PC, Molnar P et al. (1990) Effect of hyperosmotic blood-brain barrier disruption on transcapillary transport in canine brain tumors. J Neurosurg 72:441–449

    Article  PubMed  CAS  Google Scholar 

  • Hiesiger EM, Voorhies R, Basier GA et al. (1984) Comparison of 14C-methotrexate (14C-MTX) delivery by intravenous vs. intracarotid (IC) route without or with IC mannitol in experimental rat brain tumors as measured by quantitative autoradiography (QAR). Proc Am Assoc Cancer 25:363

    Google Scholar 

  • Hochberg FH, Pruitt AA, Beck DO et al. (1985) The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma. J Neurosurg 63:876–889

    Article  PubMed  CAS  Google Scholar 

  • Johnson DW, Parkinson D, Wolpert SM et al. (1987) Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma. Neurosurgery 20: 577–583

    Article  PubMed  CAS  Google Scholar 

  • Kapp JP, Sanford RA (1986) Neurologic deficit after carotid infusion of cisplatinum and 1-3-bis (2-choroethyl-1-nitrosourea (BCNU) for malignant glioma: An analysis of risk factors. Neurosurgery 19:779–783

    Article  PubMed  CAS  Google Scholar 

  • Kapp JP, Parker JL, Tucker EM (1985) Supra-ophthalmic carotid infusion for brain chemotherapy. J Neurosurg 62:823–825

    Article  PubMed  CAS  Google Scholar 

  • Layton PB, Greenberg HS, Stetson PL et al. (1984) BCNU solubility and toxicity in the treatment of maligant astrocytomas. J Neurosurg 60:1134–1137

    Article  PubMed  CAS  Google Scholar 

  • Lutz RL, Dedrick RL, Boretos JW et al. (1986) Mixing studies during intracarotid infusions in an in vitro model. J Neurosurg 64:277–283

    Article  PubMed  CAS  Google Scholar 

  • Madajewicz S, West CR, Park HC et al. (1981) Phase II study — intra-arterial BCNU therapy for metastatic brain tumors. Cancer 47:653–657

    Article  PubMed  CAS  Google Scholar 

  • Mayhein WG, Heistod DD (1985) Permeability of blood-brain barrier to various sized molecules. Am J Physiol 235:H712–H718

    Google Scholar 

  • Metes JJ, Lazo A, Wilner HI et al. (1985) Supra-ophthalmic placement of microleak balloon catheters for intracranial chemotherapy infusion: complications and results of therapy. AJNR 6:948–952

    PubMed  CAS  Google Scholar 

  • Nakagawa H, Groothius D, Blasberg RG (1984). The effect of graded hypertonic intracarotid infusions on drug delivery to experimental RG-2 gliomas. Neurology 34:1571–1581

    PubMed  CAS  Google Scholar 

  • Neuwelt EA, Barnett PA (1989) Blood-brain barrier disruption in the treatment of brain tumors: animal studies. In: Neuwelt EA (ed) Implications of the blood-brain barrier and its manipulation. Plenum Medical, New York, pp 107–193

    Chapter  Google Scholar 

  • Neuwelt EA, Dahlborg SA (1989) Blood-brain barrier disruption in the treatment of brain tumors: clinical implications. In: Neuwelt EA (ed) Implications of the blood-brain barrier and its manipulation. Plenum Medical, New York, pp 195–261

    Chapter  Google Scholar 

  • Neuwelt EA, Diehl JD, Vu LH et al. (1981) Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption. Ann Intern Med 94:449–454

    PubMed  CAS  Google Scholar 

  • Neuwelt EA, Barnett PA, Bigner DD, Frenkel EP (1982) Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier. Proc Natl Acad Sci USA 79:4420–4423

    Article  PubMed  CAS  Google Scholar 

  • Neuwelt EA, Glasberg M, Frenkel E, Barnett P (1983) Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies. Ann Neurol 14:316–324

    Article  PubMed  CAS  Google Scholar 

  • Safdari H, Mompeon B, Dubois JB, Gros C (1985) Intraarterial l,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report. Surg Neurol 24:490–497

    Article  PubMed  CAS  Google Scholar 

  • Saris SC, Blasberg RG, Carson RE et al. (1991) Intravascular streaming during carotid artery infusions: demonstration in humans and reduction using diastolephased, pulsatile administration. J Neurosurg 74:763–772

    Article  PubMed  CAS  Google Scholar 

  • Saris SC, Shook DR, Blasberg RG et al. (1987) Carotid artery mixing with diastole phased pulsed drug infusion. J Neurosurg 67:721–725

    Article  PubMed  CAS  Google Scholar 

  • Shapiro WR (1986) Therapy of adult malignant brain tumors: What have the clinical trials taught us? Semin Oncol 13(1):38–45

    PubMed  CAS  Google Scholar 

  • Shapiro WR, Ausman JI (1969) The chemotherapy of brain tumors: a clinical and experimental review. In: Plum F (ed) Recent advances in neurology. FA Davis, Philadelphia, pp 150–235

    Google Scholar 

  • Shapiro WR, Green SB (1987) Letter to the editor: Reevaluating the efficacy of intra-arterial BCNU. J Neurosurg 66:313–315

    PubMed  CAS  Google Scholar 

  • Shapiro WR, Shapiro JR (1986) Principles of brain tumor chemotherapy. Semin Oncol 13(1):56–69

    PubMed  CAS  Google Scholar 

  • Shapiro JR, Yung WK-A, Shapiro WR (1981) Isolation, karyotype and clonal growth of heterogeneous sub-populations of human malignant glioma. Cancer Res 51:2349–2359

    Google Scholar 

  • Silbergleit R, Steffey DJ, DeFilipp GJ et al. (1989) Cerebral distribution of contrast medium during slow intracarotid infusion. AJNR 10:1061–1064

    PubMed  CAS  Google Scholar 

  • Wolpert SM, Kwan ESK, Heros D et al. (1988) Selective delivery of chemotherapeutic agents with a new catheter system. Radiology 166:547–549

    PubMed  CAS  Google Scholar 

  • Yung W-KA, Shapiro WR, Shapiro JR (1982) Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. Cancer Res 42:992–998

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wolpert, S.M. (1993). Superselective Therapy for Cerebral Gliomas. In: Valavanis, A. (eds) Interventional Neuroradiology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84434-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84434-8_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-84436-2

  • Online ISBN: 978-3-642-84434-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics